FOLH1 and pachyonychia congenita: Immunohistochemical studies have reported 98% of metastatic deposits comprise a mix of both PSMA-positive and PSMA-negative cells, in both metastatic hormone-sensitive PC (mHSPC) and metastatic castration-resistant PC (mCRPC) (2).